Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The overall goal is to establish the safety and efficacy of colchicine in ICH patients for
the prevention of major cardiovascular events and brain injury. Colchicine for the prevention
of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH) is a vanguard pilot
trial designed to obtain the factual feasibility prerequisites essential for the planning,
design, funding and execution of a subsequent phase III trial.